RR
Ripal Rasiklal Khamar
About Ripal Rasiklal Khamar
Data last updated:
Ripal Rasiklal Khamar is a Director at Procyl Therapeutics Private Limited (since 2023) and Director at Provi Life Sciences Private Limited (since 2022). The companies operate in Software and Chemicals and Materials. The largest current company by reported revenue is Procyl Therapeutics Private Limited at ₹25,000 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Mar 2023 | 2023 | ₹25,000 (FY 2025) | Active | |
| Director | 04 May 2022 | 2022 | Active |
Board colleagues of Ripal Rasiklal Khamar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dharmeshkumar Amratlal Patel | 08737495 | Procyl Therapeutics Private Limited , Provi Life Sciences Private Limited | Director |
| Sivapriya Kirubakaran | 10077533 | Procyl Therapeutics Private Limited | Director |
| Vijay Thiruvenkatam | 10077532 | Procyl Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ripal Rasiklal Khamar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ripal Rasiklal Khamar
Ripal Rasiklal Khamar currently holds 2 directorships: Procyl Therapeutics Private Limited (Director, since 17 Mar 2023, revenue ₹25,000 (FY 2025)); Provi Life Sciences Private Limited (Director, since 04 May 2022).
Ripal Rasiklal Khamar was first appointed on 04 May 2022 as Director at Provi Life Sciences Private Limited. The most recent appointment on record is 17 Mar 2023 at Procyl Therapeutics Private Limited.
The current boards of Ripal Rasiklal Khamar's companies include Dharmeshkumar Amratlal Patel (Procyl Therapeutics Private Limited), Sivapriya Kirubakaran (Procyl Therapeutics Private Limited), Vijay Thiruvenkatam (Procyl Therapeutics Private Limited).